title,text,authors,publish_time,url
Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics, Clinical trials on highrisk cardiovascular patients have demonstrated their efficacy in reducing LDL-C,"Khoshnejad, Makan; Patel, Ami; Wojtak, Krzysztof; Kudchodkar, Sagar B.; Humeau, Laurent; Lyssenko, Nicholas N.; Rader, Daniel J.; Muthumani, Kar; Weiner, David B.",2019-01-02,https://doi.org/10.1016/j.ymthe.2018.10.016
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy," However, influenza-vaccinated Tc bovine IVIG therapy deserves additional evaluation as a potential therapeutic for critically ill H1N1-infected patients","Morrison, Brian J.; Roman, Jessica A.; Luke, Thomas C.; Nagabhushana, Nishith; Raviprakash, Kanakatte; Williams, Maya; Sun, Peifang",2017-10-31,https://doi.org/10.1016/j.jviromet.2017.06.007
Antibody therapies for the prevention and treatment of viral infections, 63 MHAA4549A is currently in Phase 2 clinical trials for the treatment of patients hospitalized with severe influenza A infection,"Salazar, Georgina; Zhang, Ningyan; Fu, Tong-Ming; An, Zhiqiang",2017-07-10,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627241/
Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis," 44, 45 Studies suggest that poor prenatal care and nutrition may constitute major contributory factors for such severe outcomes in selected populations","Dey, Debajit; Banerjee, Manidipa",2016-09-25,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075008/
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets,"In the absence of reliable antiviral drugs and vaccines, development of alternative strategies for influenza prophylaxis and therapy is urgently required","Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Kompier, Ronald; Goudsmit, Jaap",2010-02-08,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817000/
Preparation of recombinant vaccines," CpG ODN are currently evaluated in clinical trials in humans in the field of infectious diseases, cancer treatment and asthma/allergy","Soler, Eric; Houdebine, Louis-Marie",2007-12-31,https://doi.org/10.1016/s1387-2656(07)13004-0
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs, Centers for Disease Control and Prevention concluded that further in vitro testing of antiviral drugs on other coronavirus isolates and more information on the clinical outcome of patients treated with ribavirin or other antiviral drugs in controlled trials is needed (5) ,"Tan, Emily L.C.; Ooi, Eng Eong; Lin, Chin-Yo; Tan, Hwee Cheng; Ling, Ai Ee; Lim, Bing; Stanton, Lawrence W.",2004-04-27,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323075/
Therapeutic Applications of Monoclonal Antibodies, Many physicians use a combination of antiviral agents and immunoglobulins in patients at risk for CMV infection,"Berger, Mitchell; Shankar, Vidya; Vafai, Abbas",2002-07-31,https://doi.org/10.1097/00000441-200207000-00004
